Colorectal Cancer

An artificial intelligence tool developed at Harvard Medical School and National Cheng Kung University in Taiwan correctly predicted the aggressiveness of colorectal cancer.

Compared with reoffering colonoscopy and fecal immunochemical test alone, offering a blood test as a secondary option resulted in a nearly twofold increase in colorectal cancer screening in veterans who had declined first-line screening.

Racial disparities in gastrointestinal cancer mortality decreased in states that expanded Medicaid coverage under the Affordable Care Act while staying the same or increasing in states that did not, study results showed.

CHICAGO — A cell-free DNA blood-based test displayed 83% sensitivity for colorectal cancer detection and 90% specificity in an average-risk population, similar to the performance of current noninvasive screening options.

In this episode of Meeting Mic, we bring you Healio’s top headlines from DDW 2023.

In this podcast episode, Douglas Rex, MD, discusses the importance of intent-to-treat for colorectal screenings, how screening technology has transformed gastroenterology practice and more.

CHICAGO — Colorectal cancer screening rates at federally qualified health centers were significantly higher in states that expanded Medicaid under the Affordable Care Act vs. states that did not, according to data at Digestive Disease Week.

When we reflect on the overall impact of colorectal cancer screening over the past two decades, we see the result of a collaboration of physicians and organizations who joined forces to work toward one of our great public health successes.

Despite a decline in the overall incidence of colorectal cancer in the U.S., recent population-based data from the American Cancer Society show an alarming shift to younger age and more advanced disease at diagnosis.

The FDA announced several regulatory actions the past few weeks.